A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Summary

This is a study to test the safety and efficacy of an investigational chemotherapy agent in patients with advanced prostate cancer. Subjects who meet all entry criteria and have signed the informed consent will be enrolled in the study. Participants will be required to attend regular clinic visits to receive study medication and have their status monitored. A detailed explanation can be provided by the investigator conducting the study.

Timeline

Start

2005-02

Primary completion

2008-03

Completion

2008-03

Drugs

Indications